AVITA Medical Inc (51KB) - Net Assets
Based on the latest financial reports, AVITA Medical Inc (51KB) has net assets worth €-4.57 Million EUR (≈ $-5.34 Million USD) as of March 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€69.56 Million ≈ $81.32 Million USD) and total liabilities (€74.13 Million ≈ $86.66 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check AVITA Medical Inc (51KB) asset resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €-4.57 Million |
| % of Total Assets | -6.57% |
| Annual Growth Rate | 18.64% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 115.03 |
AVITA Medical Inc - Net Assets Trend (2019–2024)
This chart illustrates how AVITA Medical Inc's net assets have evolved over time, based on quarterly financial data. Also explore AVITA Medical Inc (51KB) total assets for the complete picture of this company's asset base.
Annual Net Assets for AVITA Medical Inc (2019–2024)
The table below shows the annual net assets of AVITA Medical Inc from 2019 to 2024. For live valuation and market cap data, see market value of AVITA Medical Inc.
| Year | Net Assets | Change |
|---|---|---|
| 2024-06-30 | €49.06 Million ≈ $57.35 Million |
-42.11% |
| 2023-06-30 | €84.74 Million ≈ $99.07 Million |
-26.73% |
| 2021-06-30 | €115.66 Million ≈ $135.21 Million |
+59.74% |
| 2020-06-30 | €72.40 Million ≈ $84.64 Million |
+247.04% |
| 2019-06-30 | €20.86 Million ≈ $24.39 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to AVITA Medical Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 16927954010.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €347.02 Million | 707.41% |
| Total Equity | €49.06 Million | 100.00% |
AVITA Medical Inc Competitors by Market Cap
The table below lists competitors of AVITA Medical Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Insight Digital Partners II Class A Ordinary Shares
NASDAQ:DYOR
|
$172.50 Million |
|
Nnit AS
CO:NNIT
|
$172.54 Million |
|
Open Lending Corp
NASDAQ:LPRO
|
$172.56 Million |
|
Strawberry Fields REIT LLC
NYSE MKT:STRW
|
$172.66 Million |
|
Tetratherix Ltd
AU:TTX
|
$172.42 Million |
|
Hope Education Group Co. Ltd
F:HE1
|
$172.39 Million |
|
Walchandnagar Industries Limited
NSE:WALCHANNAG
|
$172.39 Million |
|
Gozde Girisim Sermayesi Yatirim Ortakligi AS
IS:GOZDE
|
$172.37 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in AVITA Medical Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 84,740,000 to 49,056,000, a change of -35,684,000 (-42.1%).
- Net loss of 35,381,000 reduced equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-35.38 Million | -72.12% |
| Other Changes | €-303.00K | -0.62% |
| Total Change | €- | -42.11% |
Book Value vs Market Value Analysis
This analysis compares AVITA Medical Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.68x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 5.85x to 0.68x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-06-30 | €0.22 | €1.31 | x |
| 2020-06-30 | €3.37 | €1.31 | x |
| 2021-06-30 | €4.65 | €1.31 | x |
| 2023-06-30 | €3.36 | €1.31 | x |
| 2024-06-30 | €1.91 | €1.31 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently AVITA Medical Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -72.12%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -70.56%
- • Asset Turnover: 0.45x
- • Equity Multiplier: 2.28x
- Recent ROE (-72.12%) is below the historical average (-60.53%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -118.03% | -456.31% | 0.21x | 1.23x | €-26.71 Million |
| 2020 | -58.05% | -294.68% | 0.17x | 1.14x | €-49.27 Million |
| 2021 | -22.98% | -90.94% | 0.23x | 1.09x | €-38.15 Million |
| 2023 | -31.47% | -77.47% | 0.35x | 1.16x | €-35.14 Million |
| 2024 | -72.12% | -70.56% | 0.45x | 2.28x | €-40.29 Million |
Industry Comparison
This section compares AVITA Medical Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,036,389,730
- Average return on equity (ROE) among peers: -13.18%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| AVITA Medical Inc (51KB) | €-4.57 Million | -118.03% | N/A | $172.49 Million |
| HeraMED Limited (1I4) | $2.59 Million | -168.10% | 0.60x | $26.40 Million |
| Medtronic PLC (2M6) | $841.50 Million | 23.43% | 0.53x | $102.18 Billion |
| Peijia Medical Limited (4WO) | $2.04 Billion | -11.08% | 0.32x | $403.65 Million |
| MICROPORT CARDIO.MEDTECH. (72X) | $2.22 Billion | -2.23% | 0.20x | $107.57 Million |
| MODULIGHT OY EO 1 (78W) | $44.68 Million | -10.30% | 0.10x | $43.97 Million |
| ACOTEC SCIEN.H. DL-00001 (7W3) | $1.28 Billion | 5.50% | 0.11x | $377.38 Million |
| LIFETECH SCI.DL-00000125 (81X) | $2.53 Billion | 11.56% | 0.26x | $893.41 Million |
| ORTOMA AB B (82Y) | $142.72 Million | -13.45% | 0.13x | $26.39 Million |
| COPLAND ROAD CAPITAL NEW (A2P) | $223.54 Million | 46.04% | 1.19x | $594.67 Million |
About AVITA Medical Inc
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitili… Read more